Discover 1,398 paid clinical trials in Sarasota, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,398
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
for
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC),
Location: Sarasota FL, Tampa FL, Huntersville NC, Durham NC,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT06040541
Phase1, Recruiting
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid Malignancies
for
Advanced Solid Malignancies
Location: Sarasota FL, Nashville TN, Richmond VA, Louisville KY,
Sponsor: Georgiamune Inc
Sex: All
Age: 18+
Code: NCT06028074
Phase1, Phase2, Recruiting
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
for
Advanced Solid Tumors, Breast Cancer Recurrent, Ovarian Cancer,
Location: Sarasota FL, Nashville TN, Houston TX, Fairfax VA,
Sponsor: Accent Therapeutics
Sex: All
Age: 18+
Code: NCT06799065
Phase1, Phase2, Recruiting
A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer
for
Advanced Solid Tumor, Metastatic Breast Cancer
Location: Sarasota FL, Lake Mary FL, Nashville TN, Houston TX
Sponsor: Edgewood Oncology Inc.
Sex: All
Age: 18+
Code: NCT04872166
Phase1, Recruiting
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
for
Cancer, Cancer, Lung
Location: Sarasota FL, Celebration FL, Nashville TN, Fairfax VA,
Sponsor: Conjupro Biotherapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05948865
Phase1, Recruiting
A Phase 1/2 Study of STP938 (Dencatistat) for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas
for
Lymphoma, B-Cell, Lymphoma, T-Cell
Location: Sarasota FL, New York NY, Denver CO
Sponsor: Step Pharma, SAS
Sex: All
Age: 18+
Code: NCT05463263
Phase1, Phase2, Recruiting
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
for
Chronic Lymphocytic Leukemia (CLL),
Location: Sarasota FL, Miami FL, Atlanta GA, Durham NC,
Sponsor: Nurix Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05131022
Phase1, Recruiting
Phase 1 Study of RBN-2397, an Oral PARP7 Inhibitor, in Patients With Solid Tumors